Literature DB >> 25939560

MoCA as a Screening Tool of Neuropsychological Deficits in Alcohol-Dependent Patients.

Régis Alarcon1, Bertrand Nalpas1,2, Stéphanie Pelletier1, Pascal Perney1,3.   

Abstract

BACKGROUND: Alcoholism is known to be associated with cognitive deficits mainly concerning visuospatial capacity, executive function, memory, and attention. These impairments may affect treatment efficacy which should therefore be adapted. We evaluated the potential utility of the Montreal Cognitive Assessment (MoCA) to evaluate cognitive impairment in a large series of alcoholic patients hospitalized for withdrawal and rehabilitation.
METHODS: Consecutive recruitment during a time period of patients admitted to an addiction treatment unit of a teaching hospital. Administration of the MoCA test on admission by trained staff members.
RESULTS: A total of 166 patients aged 49.9 ± 9.2 years were included. Mean duration of administration was 20 minutes. The mean MoCA score was 23.5 ± 3.5 and 68.1% had an impaired value (<26). Age was negatively and education was positively associated with the MoCA score. Significant cognitive deficits concerned visuospatial capacity, attention, fluency, abstraction, and delayed recall. Neither age nor sex was significantly related to the MoCA score, while having a high education level (>12 years) significantly increased the likelihood of having a high MoCA score.
CONCLUSIONS: Owing to their severity and frequency, screening for cognitive deficits is necessary in alcoholics during rehabilitation. MoCA is an appropriate tool for this purpose.
Copyright © 2015 by the Research Society on Alcoholism.

Entities:  

Keywords:  Alcoholism; Cognitive Function; Screening

Mesh:

Year:  2015        PMID: 25939560     DOI: 10.1111/acer.12734

Source DB:  PubMed          Journal:  Alcohol Clin Exp Res        ISSN: 0145-6008            Impact factor:   3.455


  14 in total

1.  Cognitive Impairments in Early-Detoxified Alcohol-Dependent Inpatients and Their Associations with Socio-Demographic, Clinical and Psychological Factors: An Exploratory Study.

Authors:  Stefano Caneva; Marcella Ottonello; Elisa Torselli; Caterina Pistarini; Paola Spigno; Elena Fiabane
Journal:  Neuropsychiatr Dis Treat       Date:  2020-07-15       Impact factor: 2.570

2.  Investigation of Cognitive Improvement in Alcohol-Dependent Inpatients Using the Montreal Cognitive Assessment (MoCA) Score.

Authors:  Stéphanie Pelletier; Bertrand Nalpas; Régis Alarcon; Hélène Rigole; Pascal Perney
Journal:  J Addict       Date:  2016-12-01

3.  Cognitive Functions among Recently Detoxified Patients with Alcohol Dependence and Their Association with Motivational State to Quit.

Authors:  Athira Viswam; Padmavathi Nagarajan; Pooja Patnaik Kuppili; Balaji Bharadwaj
Journal:  Indian J Psychol Med       Date:  2018 Jul-Aug

4.  Salience network structural integrity predicts executive impairment in alcohol use disorders.

Authors:  Caterina Galandra; Gianpaolo Basso; Marina Manera; Chiara Crespi; Ines Giorgi; Giovanni Vittadini; Paolo Poggi; Nicola Canessa
Journal:  Sci Rep       Date:  2018-09-27       Impact factor: 4.379

5.  Prevalence of cognitive impairment in patients with substance use disorder.

Authors:  Carolien J W H Bruijnen; Boukje A G Dijkstra; Serge J W Walvoort; Wiebren Markus; Joanne E L VanDerNagel; Roy P C Kessels; Cornelis A J DE Jong
Journal:  Drug Alcohol Rev       Date:  2019-03-27

6.  A stepped wedge cluster randomised trial of a cognitive remediation intervention in alcohol and other drug (AOD) residential treatment services.

Authors:  Jamie Berry; Isabella Jacomb; Jo Lunn; Antoinette Sedwell; Anthony Shakeshaft; Peter J Kelly; Pooria Sarrami; Megan James; Skye Russell; Talia Nardo; Daniel Barker; Jennifer Holmes
Journal:  BMC Psychiatry       Date:  2019-02-13       Impact factor: 3.630

Review 7.  A Roadmap for Integrating Neuroscience Into Addiction Treatment: A Consensus of the Neuroscience Interest Group of the International Society of Addiction Medicine.

Authors:  Antonio Verdejo-Garcia; Valentina Lorenzetti; Victoria Manning; Hugh Piercy; Raimondo Bruno; Rob Hester; David Pennington; Serenella Tolomeo; Shalini Arunogiri; Marsha E Bates; Henrietta Bowden-Jones; Salvatore Campanella; Stacey B Daughters; Christos Kouimtsidis; Dan I Lubman; Dieter J Meyerhoff; Annaketurah Ralph; Tara Rezapour; Hosna Tavakoli; Mehran Zare-Bidoky; Anna Zilverstand; Douglas Steele; Scott J Moeller; Martin Paulus; Alex Baldacchino; Hamed Ekhtiari
Journal:  Front Psychiatry       Date:  2019-12-23       Impact factor: 4.157

8.  Tackling heterogeneity: Individual variability of emotion decoding deficits in severe alcohol use disorder.

Authors:  Pierre Maurage; Arthur Pabst; Séverine Lannoy; Fabien D'Hondt; Philippe de Timary; Baptiste Gaudelus; Elodie Peyroux
Journal:  J Affect Disord       Date:  2020-10-15       Impact factor: 4.839

9.  Developing a cognitive dysfunction risk score for use with opioid-dependent persons in drug treatment.

Authors:  Michael M Copenhaver; Victoria Sanborn; Roman Shrestha; Colleen B Mistler; Matthew C Sullivan; John Gunstad
Journal:  Drug Alcohol Depend       Date:  2021-04-24       Impact factor: 4.852

10.  The Course of Cognitive Performance during Inpatient Treatment in Patients with Alcohol Use Disorder with No, Mild or Major Neurocognitive Disorders.

Authors:  C J W H Bruijnen; S J W Walvoort; B A G Dijkstra; C A J de Jong; R P C Kessels
Journal:  Alcohol Alcohol       Date:  2021-01-04       Impact factor: 2.826

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.